李氏大藥廠：環境、社會及管治報告2024.pdf

1、2024?環境、社會及管治報告目錄CONTENTSBoard Statement 董事會聲明3Business Overview 商業概覽5About this Report 關於本報告6Reporting Period 報告期6Reporting Scope and Boundary 滙報範圍及邊界6Reporting Basis and Principles 滙報基礎及原則7Review and Approval 審閱與批核8Information and Feedbacks 反饋意見8ESG Management Structure ESG管理架構9Stakeholder Engagem

2、ent 持份者參與12Materiality Assessment 重要性評估14Materiality Matrix 重要性矩陣15Awards and Recognition 獎項及殊榮17Health and Safety 健康與安全17Corporate Social Responsibility 企業社會責任18Operating Practices 營運慣例19Product Responsibility 產品責任20Environmental Protection 環境保護21Environmental Policy 環境政策21Emissions 排放22Use of Reso

3、urces 資源使用27The Environment and Natural Resources 環境及自然資源31Climate Change 氣候變化34Employment and Labour Practices 僱傭和勞工措施41Employment 僱傭41Health and Safety 健康與安全48Development and Training 發展和培訓51Labour Standards 勞工準則54Operating Practices 營運措施55Supply Chain Management 供應鏈管理55Product Responsibility 產品責任

4、57Anti-corruption 反貪污60Community Investment 社區投資63Contribution to Different Community Aspects 於不同社區方面的貢獻63Stock Exchanges ESG Reporting Guide Index 香港聯交所 環境、社會及管治報告指引 內容索引72GRI Content Index GRI永續性報導準則內容索引80TCFD Content Index 氣候相關財務揭露內容索引表93SDGs Content Index 永續發展目標內容索引表95Environmental,Social and Go

5、vernance Report 2024 環境、社會及管治報告3Board Statement董事會聲明On behalf of the board(the“Board”)of directors(the“Directors”)of the Lees Pharmaceutical Holdings Limited(the“Company”)and its subsidiaries(collectively,the“Group”or“Lees Pharm”or“we”or“us”),I hereby present to you the 2024 Environmental,Social and

6、 Governance(“ESG”)Report(this“Report”),providing an overview of the Groups approach,performance and commitment on material corporate sustainability issues that have impacts on our operation.The Group puts the sustainable development of its business as the top priority of its long-term development go